LGALS3 and hydrops fetalis: Despite the identification of promising candidates, including markers of fibrosis (ST2, Gal-3), myocardial injury (cardiac troponins), inflammation (GDF-15) and kidney injury (LCN2) for both prediction of and prognosis in HF, these biomarkers have not yet been translated into clinical practice and have limited support specifically for HFpEF7.